RxDoctor Payments Data

Angela Vallejo, PA

Physician Assistant · Cape Coral, FLNPI 1841514619

Payments from drug & device makers

$9,115in general payments, 2019–2025

Across 495 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$823
  • GSK$811
  • Merck$709
  • Novo Nordisk$648
  • AbbVie$542
  • Sumitomo Pharma America, Inc.$497
  • plus $5K from 43 others

What the payments were for

  • Food & beverage$8,87097%
  • Education$2453%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,115 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$87,179
Medicare patients
239
Services billed
2,730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide90$105,497
LinzessLinaclotide67$55,226
OzempicSemaglutide38$49,537
EliquisApixaban49$46,392
TrulicityDulaglutide34$43,539
FarxigaDapagliflozin Propanediol43$41,696
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$33,368
XareltoRivaroxaban32$30,745
ProliaDenosumab17$29,501
VascepaIcosapent Ethyl59$25,321
Repatha SureclickEvolocumab24$19,932
JardianceEmpagliflozin14$18,172
Breo ElliptaFluticasone/Vilanterol29$17,977
GemtesaVibegron23$17,912
MyrbetriqMirabegron13$12,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$398$149,037124 claims
AbbVieLinzess, Synthroid$542$58,30295 claims
GSKTrelegy Ellipta, Breo Ellipta$811$51,34468 claims
AstraZenecaFarxiga, Breztri Aerosphere$261$49,64255 claims
Novo NordiskOzempic$648$49,53738 claims
PfizerEliquis$192$46,39249 claims
Johnson & JohnsonXarelto$385$30,74532 claims
AmgenProlia$823$29,50117 claims
Boehringer IngelheimJardiance$82$18,17214 claims
Sumitomo Pharma America, Inc.Gemtesa$497$17,91223 claims
Astellas Pharma US IncMyrbetriq$423$12,09913 claims
NovartisEntresto$221$9,59711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Cape Coral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →